Please assess the completion status of the following clinical trial:

Trial Title: Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* 1-3 oral treatments~* Insulin naive~* BMI (Body Mass Index) less than or equal to 45~Exclusion Criteria:~* Pregnancy~* Retinopathy~* Cardiac disease~* Uncontrolled hypertension~* Recurrent hypoglycaemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FPG 70-90 mg/dL (Type: EXPERIMENTAL): Aggressive FPG (fasting plasma glucose) titration target range group
- FPG 80-110 mg/dL (Type: EXPERIMENTAL): Conventional FPG (fasting plasma glucose) titration target range group

Based on this trial design, predict the completion outcome and termination type (if applicable).